Diagnostic issues in chronic lymphocytic leukaemia (CLL)

Best Practice & Research. Clinical Haematology
Estella MatutesDaniel Catovsky

Abstract

The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. Morphology and immunophenotype are the initial diagnostic investigations. In atypical cases, these tests should be complemented with molecular genetics and/or histology to exclude other B-cell disorders of small lymphocytes. Morphologically, CLL can be classified into typical and atypical. Immunophenotyping is the only method that can establish or confirm the diagnosis as CLL lymphocytes have a distinct immunophenotypic signature. A scoring system compounding the results with a set of markers allows firming up the diagnosis. Other immunological markers such as CD38 and ZAP-70 have an important prognostic impact. Fluorescence in situ hybridization (FISH) analysis, chiefly by detecting 17p (TP53 locus) and 11q (ATM) deletions and mutational status of the IgVH gene, also provides prognostic information and may determine the type of therapy. In atypical CLL, histology and/or molecular genetics may be required to exclude other B-cell disorders.

References

Jan 1, 1979·British Journal of Haematology·A EnnoD A Galton
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Feb 13, 2003·British Journal of Haematology·Georges JungPhilippe Hénon
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Nov 7, 2008·The New England Journal of Medicine·Christopher S MulliganStephen P Mulligan
Feb 12, 2009·Hematological Oncology·Davide Rossi, Gianluca Gaidano
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grzegorz S NowakowskiNeil E Kay
May 27, 2009·European Journal of Haematology·Zaid AbboudiKikkeri N Naresh
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide RossiGianluca Gaidano

❮ Previous
Next ❯

Citations

Dec 3, 2013·Leukemia & Lymphoma·Pauline Y HuangRichard I Christopherson
Oct 26, 2011·Leukemia & Lymphoma·Pauline Y HuangRichard I Christopherson
Jan 10, 2014·International Journal of Laboratory Hematology·S MarionneauxE M Keohane
Sep 23, 2016·Journal of the Neurological Sciences·Ana MonteiroGoreti Nadais
Feb 3, 2015·Therapeutic Advances in Hematology·Valentín Ortiz-MaldonadoJulio Delgado
Oct 6, 2018·International Journal of Laboratory Hematology·Marc Sorigue, Jordi Junca
Mar 28, 2013·Integrative Biology : Quantitative Biosciences From Nano to Macro·Ehsan Ghayoor Karimiani, Philip Day
Apr 11, 2019·Expert Opinion on Drug Metabolism & Toxicology·Anna Korycka-WolowiecTadeusz Robak
Dec 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yair HerishanuBen-Zion Katz
Nov 18, 2018·BMC Research Notes·Enaam Abdelrhman AbdelgaderTarig H Merghani
Sep 15, 2014·BMC Research Notes·Simone Lima de SouzaMaria Helena Ornellas

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Related Papers

Best Practice & Research. Clinical Haematology
Estella MatutesDaniel Catovsky
Seminars in Cancer Biology
Ulf Klein, Riccardo Dalla-Favera
Current Opinion in Hematology
Lynn GoldinNeil E Caporaso
© 2021 Meta ULC. All rights reserved